BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2768543)

  • 21. Trazodone, a triazolopyridine derivative, in primary depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1980 Jul; 41(7):250-5. PubMed ID: 6993447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of monoamine oxidase inhibitor-associated insomnia with trazodone.
    Nierenberg AA; Keck PE
    J Clin Psychopharmacol; 1989 Feb; 9(1):42-5. PubMed ID: 2708555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant properties of trazodone.
    Bryant SG; Ereshefsky L
    Clin Pharm; 1982; 1(5):406-17. PubMed ID: 6764164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steady-state plasma levels during antidepressant therapy with amitriptyline and amitriptylinoxide.
    Koch H
    Isr J Psychiatry Relat Sci; 1990; 27(1):48-56. PubMed ID: 2194992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trazodone dosing regimen: experience with single daily administration.
    Fabre LF
    J Clin Psychiatry; 1990 Sep; 51 Suppl():23-6. PubMed ID: 2211561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desipramine plasma levels and response in elderly melancholic patients.
    Nelson JC; Jatlow PI; Mazure C
    J Clin Psychopharmacol; 1985 Aug; 5(4):217-20. PubMed ID: 4019810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine?
    Spreux-Varoquaux O; Gailledreau J; Vanier B; Bothua D; Plas J; Chevalier JF; Advenier C; Pays M; Brion S
    Biol Psychiatry; 1996 Sep; 40(6):465-73. PubMed ID: 8879466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Kane JM; Cole K; Sarantakos S; Howard A; Borenstein M
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients.
    Mihara K; Yasui-Furukori N; Kondo T; Ishida M; Ono S; Ohkubo T; Osanai T; Sugawara K; Otani K; Kaneko S
    Ther Drug Monit; 2002 Aug; 24(4):563-6. PubMed ID: 12142643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma concentrations of trazodone and m-chlorophenylpiperazine at steady state can be predicted from those after an initial dose of trazodone.
    Otani K; Mihara K; Yasui N; Ishida M; Kondo T; Tokinaga N; Ohkubo T; Osanai T; Sugawara K; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):239-44. PubMed ID: 9075270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of trazodone on the sleep of depressed subjects--a polygraphic study.
    Mouret J; Lemoine P; Minuit MP; Benkelfat C; Renardet M
    Psychopharmacology (Berl); 1988; 95 Suppl():S37-43. PubMed ID: 3133713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended-release trazodone (Oleptro) for depression.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):91-2. PubMed ID: 21068704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of serum levels of trazodone produced in man following single or repeated oral administrations.
    Allori L; Catanese B; Cioli V; Interdonato N
    Boll Chim Farm; 1978 Sep; 117(9):530-3. PubMed ID: 752360
    [No Abstract]   [Full Text] [Related]  

  • 36. [Plasma levels of metapramine and its 3 major metabolites in patients with depression. Results and preliminary interpretations].
    Bougerol T; Gouezo F; Pok Phak Rop P; Valli M; Durand A; Conquy T; Scotto JC; Viala A
    Encephale; 1990; 16(1):35-40. PubMed ID: 2328683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential dosing of trazodone in elderly depressed patients: a study to investigate optimal dosing.
    Mukherjee PK; Davey A
    J Int Med Res; 1986; 14(5):279-84. PubMed ID: 3533676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validity.
    Bertschy G; Vandel S; Vandel B; Allers G; Bechtel P; Volmat R
    Pharmacopsychiatry; 1989 Jul; 22(4):161-4. PubMed ID: 2762378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients.
    Fudge JL; Perry PJ; Garvey MJ; Kelly MW
    J Affect Disord; 1990 Apr; 18(4):275-80. PubMed ID: 2140380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute stimulant response prediction of chronic trazodone effects.
    Little KY; Gay TL
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):815-24. PubMed ID: 8870066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.